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Abstract 
A 50-year-old woman is described with a very unusual combination of MEN-l syndrome with a negative family history. 
At first she had been treated because of a clinically non-functioning pituitary adenoma in the maxillary sinus. Six years later 
a carcinoid tumour was discovered by means of “‘In-pentreotide scintigraphy. 
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1. Introduction 
Carcinoid tumours may be part of the multiple 
endocrine neoplasia (MEN) syndromes 1 and 2, al- 
though more common in MEN-l [ 11. Parathyroid 
adenomas are the most common feature of MEN-l 
[2]. Carcinoids, hormone-secreting pancreatic islet- 
cell tumours, pituitary adenomas, of which 13% are 
hormonally inactive, and adrenocortical tumours can 
also be part of the syndrome 131. We describe a 
50-year-old woman with a carcinoid tumour of the 
caecum who had been previously treated for a clini- 
cally non-functioning pituitary adenoma in the max- 
illary sinus (Ref. [4], patient 6). 
* Corresponding author, present address: Department of Inten- 
sive Care, St. Radboud Ziekenhuis, PO Box 9101, 6500 HB, 
Nijmegen, Netherlands. 
2. Case report 
A 50-year-old Caucasian female presented to our 
department because of pain in the right lower ab- 
dominal quadrant and loss of appetite. In the last 4 
months, she had lost 3 kg weight and had suffered 
attacks of diarrhoea once a week. In the last weeks 
before admission the pain increased and she devel- 
oped complaints of nausea and sometimes she had to 
vomit. There were no complaints of flushing or 
shortness of breath. An appendectomy had been 
performed 24 years before. Her family history was 
negative for endocrine tumours. 
Six years before admission she underwent an 
operation of the left maxillary sinus because of a 
tumour. At first this tumour was diagnosed as an 
aesthesioneuroblastoma, and she underwent locally 
applied chemotherapy and external radiation therapy. 
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Fig. 1. ” ’ In-pentetreotide (OctreoScan) image in the anterior 
plane obtained 96 h after injection. Physiological uptake in the 
liver, spleen and kidneys is shown. Note area of increased uptake 
in the right lower abdominal quadrant (arrow). Some activity is 
also present in the bowel. 
Revision of the tumour pathology showed that it was 
a clinically non-functioning ‘ectopic’ pituitary ade- 
noma. A postoperative CT-scan showed normal bony 
sellar margins while the anterior pituitary function 
had remained normal. [4] 
Four years before admission she had also visited 
our department because of abdominal pain and vom- 
iting. Standard radiographs of the abdomen showed a 
few air-fluid levels which disappeared after conser- 
vative treatment. Colonoscopy (by which the termi- 
nal ileum could be reached), a small-bowel follow- 
through examination and computer tomography (CT) 
of the abdomen showed no abnormalities. An ” ‘In- 
pentetreotide scintigram (OctreoScan, Malinckrodt, 
Petten, Netherlands), which was performed as part of 
a study of pituitary tumours, showed unexpectedly a 
‘hot spot’ in the right lower quadrant of the ab- 
domen. 5-Hydroxyindole acetic acid (5-HIAA) ex- 
cretion in the urine was within normal limits. The 
patient recovered spontaneously at that time and had 
been regularly followed in our outpatient clinic. 
At the present hospital admission the patient ap- 
peared well. On physical examination there was 
slight tenderness in the lower part of the right side of 
the abdomen. No masses were felt. There were no 
signs of right-sided heart failure. 
Routine laboratory results showed no abnormali- 
ties. Serum calcium amounted to 2.40 mmol/l, albu- 
men 46 g/l and PTH(l-84) 14.9 rig/l (N). Urinary 
5-HIAA excretion varied between 28.2 and 36.6 
kmo1/24 h; incidentally a value of 50.9 kmo1/24 h 
Fig. 2. Section through mucosa and submucosa of the colon. Carcinoid tumour (short arrow), normal mucosa (long arrow). Haematoxylin- 
eosin; original magnification X 25. 
was obtained (N < 50 p,mo1/24 h). Colonoscopic 
examination was without abnormalities, but the cae- 
cum could not be reached because it seemed to be 
flexed dorsally. A small-bowel follow-through 
showed no abnormalities. Ultrasound examination 
showed a normal liver and a slightly enlarged 
lymph-node in the painful area of the abdomen. An 
ultrasound-guided fine needle aspiration was per- 
formed. Cytological examination showed cohesive 
clusters of small neoplastic cells with round or oval 
nuclei, stippled nuclear chromatin and small amounts 
of intact cytoplasm suggestive of carcinoid tumour. 
’ ’ ’ In-pentetreotide scintigraphy was repeated, but 
only showed the ‘hot spot’ in the abdomen at exactly 
the same location as found 2 years previously; the 
liver showed no abnormalities (Fig. I). At midline 
laparotomy, a small tumour with a diameter of 1 cm 
was found in the mesentery at the ileocaecal junc- 
tion. A fibrotic band extending from this tumour had 
resolved in a stenosis of the terminal ileum. A right 
hemicolectomy was performed. Ultrasound examina- 
tion during the operation did not show any abnormal- 
ities in the para-aortic region or in the liver. 
The ascending colon revealed a submucosal eleva- 
tion approximately 1 cm in diameter. On transection 
it was firm, yellow and infiltrated into the subserosal 
fat. Histologically, the lesion was composed of small 
nests and strands of epithelial cells. The cells were 
quite regular, with uniform round to oval nuclei and 
infrequent mitosis (Fig. 2). Silver impregnation tech- 
niques (Grimelius staining) and immuno-histochemi- 
cal staining for chromogranin and serotonin were 
positive. 
Postoperative values for 5-HIAA excretion in the 
urine varied between 18.1 and 32.2 pmo1/24 h. An 
“I In-pentetreotide scan no longer showed any up- 
take in the abdominal region. During follow-up (2 
years) signs of bowel obstruction did not recur. 
3. Discussion 
The occurrence of tumours involving two or more 
endocrine glands is characteristic for MEN [3,5]. 
Typically the MEN-l syndrome consists of tumours 
of the parathyroid glands in 90% [6], of the pancre- 
atic islet-cells in 30-75% and of the anterior pitu- 
itary in 15-90% of cases; 12% of the latter tumours 
are clinically non-functioning [5]. During screening 
83 to 100% of the relatives become clinically or 
biochemically positive [S]. In this case-report we 
describe a patient who first presented with an 
‘ectopic’, clinically non-functioning pituitary ade- 
noma and developed a carcinoid tumour in the cae- 
cum several years later. The history of the family 
was negative for MEN-l. There was no hyper- 
parathyroidism. At a previous admission the carci- 
noid tumour had not been found, even though ’ ’ ’ In- 
pentetreotide scintigraphy had been positive in this 
region. 5-HIAA excretion in the urine was normal, 
probably because there was no involvement of the 
liver. 
Episodic flushing and diarrhoea are the most com- 
mon features of a carcinoid tumour. Right-sided 
heart failure, wheezing and pellagra may also be part 
of the disease [7,8]. Midgut carcinoids produce 
symptoms as soon as there is involvement of the 
liver. However. small carcinoids may also cause 
diarrhoea because they are able to induce mesenteric 
fibrosis resulting in twisting, intestinal obstruction, 
bacterial overgrowth, discontinuation of intestinal 
blood supply and mesenteric infarction [9]. Carcinoid 
tumours normally secrete serotonin but are also able 
to secrete tachykinins and substance P [lo]. The 
metabolite of serotonin-5-hydroxyindole acetic acid 
(5-HIAA), which can be measured in the urine--is 
generally accepted as the diagnostic hall-mark of the 
carcinoid syndrome. 
Gastro-entero-pancreatic tumours, carcinoids and 
other APUDoma’s (Amine Precursor Uptake and 
Decarboxylation) like pituitary tumours can be suc- 
cessfully visualised by means of ” ’ In-pentetreotide 
scintigraphy; the sensitivity of this method is 60-92% 
[ 11-l 51. However, granulomas like those found in 
tuberculosis, sarcoidosis, Wegener’s granulomatosis 
and lymphomas can also be visualized, making this 
method unsuitable for the differential diagnosis [ 121. 
We conclude that ” ‘In-pentetreotide scintigraphy 
in patients known to have pituitary tumours or pri- 
mary hyperparathyroidism and complaints of the gas- 
trointestinal tract, showing consistent areas of in- 
creased uptake of radioactivity in the abdomen, 
should arouse clinical suspicion of a potential locali- 
sation of an APUDoma within the spectrum of the 
MEN- I syndrome. 
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